Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
Total Valuation
Mankind Pharma Ltd. has a market cap or net worth of ₹847.99B. The enterprise value is ₹936.36B.
Market Cap₹847.99B
Enterprise Value₹936.36B
Share Statistics
Mankind Pharma Ltd. has 412,828,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,828,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mankind Pharma Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.00%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.00%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee6.25M
Profits Per Employee1.02M
Employee Count19,540
Asset Turnover0.44
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of Mankind Pharma Ltd. is 55.5. Mankind Pharma Ltd.’s PEG ratio is 16.80.
PE Ratio55.5
PS Ratio8.15
PB Ratio6.94
Price to Fair Value6.94
Price to FCF50.94
Price to Operating Cash Flow52.44
PEG Ratio16.80
Income Statement
In the last 12 months, Mankind Pharma Ltd. had revenue of 122.07B and earned 19.91B in profits. Earnings per share was 49.17.
Revenue122.07B
Gross Profit86.38B
Operating Income25.16B
Pretax Income25.16B
Net Income19.91B
EBITDA35.58B
Earnings Per Share (EPS)49.17
Cash Flow
In the last 12 months, operating cash flow was 16.37B and capital expenditures -2.71B, giving a free cash flow of 13.66B billion.
Operating Cash Flow16.37B
Free Cash Flow13.66B
Free Cash Flow per Share33.08
Dividends & Yields
Mankind Pharma Ltd. pays an annual dividend of ₹1, resulting in a dividend yield of 0.04%
Dividend Per Share₹1
Dividend Yield0.04%
Payout Ratio2.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-11.56%
50-Day Moving Average2.09K
200-Day Moving Average2.32K
Relative Strength Index (RSI)51.61
Average Volume (3m)10.08K
Important Dates
Mankind Pharma Ltd. upcoming earnings date is Jun 2, 2026, Before Open (Confirmed).
Last Earnings DateFeb 3, 2026
Next Earnings DateJun 2, 2026
Ex-Dividend Date―
Financial Position
Mankind Pharma Ltd. as a current ratio of 1.23, with Debt / Equity ratio of 54.75%
Current Ratio1.23
Quick Ratio0.86
Debt to Market Cap0.09
Net Debt to EBITDA2.24
Interest Coverage Ratio6.17
Taxes
In the past 12 months, Mankind Pharma Ltd. has paid 5.10B in taxes.
Income Tax5.10B
Effective Tax Rate0.20
Enterprise Valuation
Mankind Pharma Ltd. EV to EBITDA ratio is 30.19, with an EV/FCF ratio of 55.02.
EV to Sales8.80
EV to EBITDA30.19
EV to Free Cash Flow55.02
EV to Operating Cash Flow44.51
Balance Sheet
Mankind Pharma Ltd. has ₹31.05B in cash and marketable securities with ₹83.69B in debt, giving a net cash position of -₹52.64B billion.
Cash & Marketable Securities₹31.05B
Total Debt₹83.69B
Net Cash-₹52.64B
Net Cash Per Share-₹127.51
Tangible Book Value Per Share-₹50.61
Margins
Gross margin is 63.25%, with operating margin of 20.61%, and net profit margin of 16.31%.
Gross Margin63.25%
Operating Margin20.61%
Pretax Margin20.61%
Net Profit Margin16.31%
EBITDA Margin29.15%
EBIT Margin24.06%
Analyst Forecast
The average price target for Mankind Pharma Ltd. is ₹2,800.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2,800.00
Price Target Upside27.13% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast23.22%
EPS Growth Forecast-19.19%